The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
Abstract
UNLABELLED: Lymphatic drainage plays an important role in the uptake of particulates in the respiratory system, being also associated to the spreading of lung cancer through metastasis development. In recent years solid lipid nanoparticles (SLN) have been proposed as carriers of anti-tumoural drugs, for their low toxicity and surface characteristics make them suitable for either imaging (gamma-scintigraphy) or therapy upon encapsulation of cytotoxic drugs. Assessment of inhaled radiolabelled SLN biodistribution is described in the present work. METHODS: Nanoparticles (200 nm) were radiolabelled with 99mTc using the lipophilic chelator D,L-hexamehylpropyleneamine oxime (HMPAO). Biodistribution studies were carried out following aerosolisation and administration of a 99mTc-HMPAO-SLN suspension to a group of adult male Wistar rats. A 60 min dynamic image acquisition was performed in a gamma-camera, followed by static image collection at 30 min intervals up to 4 h postinhalation. Radiation counting was performed in organ samples, collected after the animals were sacrificed. RESULTS: The data show an important and significant uptake of the radiolabelled SLN into the lymphatics after inhalation, and a high rate of distribution in periaortic, axillar and inguinal lymph nodes. CONCLUSION: Results indicate that SLN could be effective colloidal carriers for lymphoscintigraphy or therapy upon pulmonary delivery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lipid NPs show higher stability and drug loading efficiency with appropriate sizes and shapes for direct lung targeting and controlled drug delivery.213”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [213]
Citations
Cites
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,158
The Lung: Scientific Foundations
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-503_2 · Cited by 1,183
Microsatellite alterations in plasma DNA of small cell lung cancer patients
Chen, X. Q., Stroun, M., Magnenat, J.-L., Nicod, L. P., Kurt, A.-M., Lyautey, J., Lederrey, C., & Anker, P. (1996) · Nature Medicine · doi:10.1038/nm0996-1033 · Cited by 647
The Role of Macrophages in Particle Translocation from Lungs to Lymph Nodes
Harmsen, A. G., Muggenburg, B. A., Snipes, M. B., & Bice, D. E. (1985) · Science · doi:10.1126/science.4071052 · Cited by 326
Lymphatic targeting with nanoparticulate system
Nishioka, Y., & Yoshino, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00121-6 · Cited by 221
Solid Lipid Nanoparticles in Lymph and Plasma After Duodenal Administration to Rats
Bargoni, A., Cavalli, R., Caputo, O., Fundaro', A., Gasco, M. R., & Zara, G. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011975120776 · Cited by 148
Juliano, R. L., & McCullough, H. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32184-1 · Cited by 87
Sharma, D., Chelvi, T. P., Kaur, J., Chakravorty, K., De, T., Maitra, A. N., & Ralhan, R. (1996) · PubMed · Cited by 85
The migration of bronchoalveolar macrophages into hilar lymph nodes.
Corry, D. B., Kulkarni, P. V., & Lipscomb, M. F. (1984) · PubMed · Cited by 79
Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats
Maincent, P., Thouvénot, P., Amicabile, C., Hoffman, M., Kreuter, J., Couvreur, P., & Devissaguet, J. P. (1992) · Pharmaceutical Research · doi:10.1023/a:1015895804597 · Cited by 76
Cited by
Sorted by citations
Items 201–210 of 210
Al-Hallak, M. K. (2012) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3rk6t
Antisense Oligonucleotide-Mediated Target-Specific Gene Silencing
Maiti, S., & Sen, K. K. (2016) · CRC Press eBooks · doi:10.1201/9781315370118-13
DEVELOPMENT, OPTIMIZATION AND CHARACTERIZATION OF FEBUXOSTAT LOADED SOLID LIPID NANO PARTICLES
(2021) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2021/10.10.1018
Sarker, D. K. (2013) · Wiley eBooks · doi:10.1002/9781118648384.refs
Improved pulmonary drug delivery through nanocarriers
Shah, M. R., Imran, M., & Ullah, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821093-2.00008-6
Maiti, S., & Sen, K. K. (2016) · CRC Press eBooks · doi:10.1201/9781315370118-8
Routes of Administration for Carriers for Lymphatic Delivery
Tagoe, B., Gyamfi, D., Ofori, E. K., Quaye, B., & Amponsah, S. K. (2024) · Springer eBooks · doi:10.1007/978-3-031-64828-1_15
Aerodynamics and deposition of lipid-based nanocarriers in the lungs
Alam, M. I., Ali, H., & Akbar, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22374-7.00004-9
Metadata
- Authors
- Videira, M. A., Botelho, M. F., Santos, A. C., Gouveia, L. F., Pedroso de Lima, J. J., & Almeida, A. J.
- Affiliations
- University of Lisbon (PT)
- University of Coimbra (PT)
- Venue
- Journal of Drug Targeting
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 10
- Issue
- 8
- Pages
- 607-613
- ISSN
- 1026-7158 (ISSN-L)
- 1061-186X
- 1029-2330
- OpenAlex
- W2115533786
- Cited by
- 213
- References
- 25
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 9 · 2023: 8 · 2022: 10 · 2021: 14 · 2020: 10 · 2019: 7 · 2018: 11 · 2017: 8 · 2016: 14 · 2015: 12 · 2014: 12 · 2013: 14 · 2012: 14
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of drug targeting (publishedVersion)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Funders
- Fundação para a Ciência e a Tecnologia
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- solid lipid nanoparticles, lymphatic absorption, pulmonary drug delivery, aerosol inhalation, 99mTc-HMPAO, tissue distribution, lymphoscintigraphy, lymph node distribution, lung cancer metastasis, scintigraphy, nanoparticle drug carriers
- MeSH terms
- Administration, Inhalation, Animals, Colloids, Drug Carriers, Image Processing, Computer-Assisted, Isotope Labeling, Lipids, Lung, Lymphatic System, Male, Microspheres, Spirometry, Tissue Distribution, Rats, Wistar, Radiopharmaceuticals, Technetium Tc 99m Exametazime, Rats, Lymphoscintigraphy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
